Hyperbaric Oxygen and Sudden Sensorineural Hearing Loss: A Systematic Review and Meta‐Analysis
The Laryngoscope · 2026-01 · 136 (1) · 91-101
DOI: 10.1002/lary.32472 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Laryngoscope, online erschienen am 01.08.2025. Verfasst von Isaac L Alter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian/Columbia Uni…. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Hearing Loss, Sensorineural, Hearing Loss, Sudden. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Objective
Sudden sensorineural hearing loss ( SSNHL ) Remains a significant enigma, despite its profound impacts on affected individuals. Hyperbaric oxygen therapy ( HBOT ) has gained significant attention as a potential treatment, but its use remains controversial. We aimed to perform a systematic review and meta‐analysis assessing the efficacy of HBOT in treating SSNHL . Data Sources PubMed, EMBASE, CENTRAL, MEDLINE, Google Scholar, Web of Science, and Clinicaltrials.gov were searched through May 7, 2025. Review Methods Two investigators independently screened articles and extracted data in line with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. A meta‐analysis calculated pooled odds ratios (ORs) using a random‐effects model.
Results
Twenty studies (16 RCTs and four non‐randomized prospective studies) were included; in total, these studies investigated 1087 patients receiving HBOT and 600 receiving medical therapy ( MT ) alone. Ten studies were included in a meta‐analysis, which found that patients receiving HBOT in combination with MT had 2.61 higher odds of experiencing hearing recovery than those treated with MT alone (95% CI 1.86–3.68, p < 0.001). Subgroup analyses for HBOT + systemic steroids ( SS ) vs. SS alone and HBOT + SS + intratympanic steroids ( ITS ) vs. SS + ITS alone found higher odds of hearing recovery with HBOT ( OR 2.54, 95% CI 1.63–3.97, p < 0.001 and OR 2.64, 95% CI 1.39–5.02, p < 0.001, respectively).
Conclusion
The combination of HBOT with MT is likely to provide benefit in hearing recovery for individuals with SSNHL. However, ongoing work should seek to standardize treatment protocols and data reporting to allow for more definitive conclusions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA.
- Tampa Bay Hearing and Balance Center, Tampa, Florida, USA.
- Department of Biostatistics, Columbia University Mailman School of Public Health, New York, New York, USA.
- Augustus C. Long Health Sciences Library, Columbia University Irving Medical Center, New York, New York, USA.
- Department of Mechanical Engineering, Fu Foundation School of Engineering and Applied Science, Columbia University, New York, New York, USA.
ORCID-Profile: Isaac L Alter, Anil K Lalwani
Zitieren
APA
Alter, I. L., Hamiter, M., Han, J., Leu, C. S., Usseglio, J., & Lalwani, A. K. (2026). Hyperbaric Oxygen and Sudden Sensorineural Hearing Loss: A Systematic Review and Meta‐Analysis. The Laryngoscope, 136(1), 91-101. https://doi.org/10.1002/lary.32472
Vancouver
Alter IL, Hamiter M, Han J, Leu CS, Usseglio J, Lalwani AK. Hyperbaric Oxygen and Sudden Sensorineural Hearing Loss: A Systematic Review and Meta‐Analysis. The Laryngoscope. 2026;136(1):91-101. doi:10.1002/lary.32472
BibTeX
@article{Alter2026,
author = {Alter, Isaac L and Hamiter, Mickie and Han, Jiying and Leu, Cheng-Shiun and Usseglio, John and Lalwani, Anil K},
title = {Hyperbaric Oxygen and Sudden Sensorineural Hearing Loss: A Systematic Review and Meta‐Analysis},
journal = {The Laryngoscope},
year = {2026},
volume = {136},
number = {1},
pages = {91--101},
doi = {10.1002/lary.32472}
}
EUVIMED